Charles River Laboratories International, Inc. (CRL)
Market Open
5 Dec, 19:09
$
185. 62
+1.58
+0.86%
$
8.81B Market Cap
- P/E Ratio
0.4% Div Yield
33,787 Volume
- Eps
$ 184.04
Previous Close Day Range
182.71 185.71
Year Range
91.86 202.72
Want to track CRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days
| CRL Charles River Laboratories International, Inc. 18 Feb 2026 (In 2 months) | | 2.32 Cons. EPS | - EPS |
| CRL Charles River Laboratories International, Inc. 5 Nov 2025 | | 2.35 Cons. EPS | 2.43 EPS |
| CRL Charles River Laboratories International, Inc. 29 Oct 2025 | | 2.38 Cons. EPS | - EPS |
| CRL Charles River Laboratories International, Inc. 30 Jul 2025 | | 2.5 Cons. EPS | - EPS |
| CRL Charles River Laboratories International, Inc. 7 May 2025 | | 2.07 Cons. EPS | 2.34 EPS |
| CRL Charles River Laboratories International, Inc. 12 Feb 2025 | | 2.53 Cons. EPS | 2.66 EPS |
| CRL Charles River Laboratories International, Inc. 6 Nov 2024 | | 2.43 Cons. EPS | 2.59 EPS |
| CRL Charles River Laboratories International, Inc. 7 Aug 2024 | | 2.39 Cons. EPS | 2.8 EPS |
| CRL Charles River Laboratories International, Inc. 9 May 2024 | | 2.07 Cons. EPS | 2.27 EPS |
| CRL Charles River Laboratories International, Inc. 14 Feb 2024 | | 2.4 Cons. EPS | 2.46 EPS |
| CRL Charles River Laboratories International, Inc. 8 Nov 2023 | | 2.37 Cons. EPS | 2.72 EPS |
| CRL Charles River Laboratories International, Inc. 2 Nov 2016 | | 1.13 Cons. EPS | 1.18 EPS |
| CRL Charles River Laboratories International, Inc. 3 Aug 2016 | | 1.1 Cons. EPS | 1.2 EPS |
| CRL Charles River Laboratories International, Inc. 4 May 2016 | | 0.9 Cons. EPS | 0.98 EPS |
| CRL Charles River Laboratories International, Inc. 10 Feb 2016 | | 0.94 Cons. EPS | 1 EPS |
| CRL Charles River Laboratories International, Inc. 4 Nov 2015 | | 0.94 Cons. EPS | 1.03 EPS |
| CRL Charles River Laboratories International, Inc. 30 Jul 2015 | | 0.97 Cons. EPS | 0.96 EPS |
| CRL Charles River Laboratories International, Inc. 29 Apr 2015 | | 0.82 Cons. EPS | 0.79 EPS |
| CRL Charles River Laboratories International, Inc. 10 Feb 2015 | | 0.71 Cons. EPS | 0.81 EPS |
| CRL Charles River Laboratories International, Inc. 29 Oct 2014 | | 0.8 Cons. EPS | 0.86 EPS |
| CRL Charles River Laboratories International, Inc. 6 Aug 2014 | | 0.82 Cons. EPS | 0.97 EPS |
| CRL Charles River Laboratories International, Inc. 30 Apr 2014 | | 0.74 Cons. EPS | 0.82 EPS |
| CRL Charles River Laboratories International, Inc. 11 Feb 2014 | | 0.68 Cons. EPS | 0.73 EPS |
| CRL Charles River Laboratories International, Inc. 29 Oct 2013 | | 0.7 Cons. EPS | 0.79 EPS |
| CRL Charles River Laboratories International, Inc. 31 Jul 2013 | | 0.71 Cons. EPS | 0.73 EPS |
| CRL Charles River Laboratories International, Inc. 1 May 2013 | | 0.71 Cons. EPS | 0.69 EPS |
| CRL Charles River Laboratories International, Inc. 13 Feb 2013 | | 0.6 Cons. EPS | 0.64 EPS |
CRL Earnings Reports FAQ
What is the earnings per share (EPS) for CRL?
EPS data for CRL is currently not available, as Charles River Laboratories International, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 11.76%, reflecting the CRL's performance and NYSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-18, based on the CRL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 2.43 per share, reported on 2025-11-05. For dividend history, visit the CRL Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 76.39, calculated based on the most recent stock price of $185.62.
2025 © Marketlog. All Rights Reserved.
